{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:42:54Z","timestamp":1789731774998,"version":"4.0.1"},"reference-count":30,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["11-05-2018"],"award-info":[{"award-number":["11-05-2018"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbott","award":["24-05-2018"],"award-info":[{"award-number":["24-05-2018"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,8,19]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Left atrial appendage closure (LAAC) is recommended to decrease the stroke risk in patients with atrial fibrillation and contraindications to anticoagulation. However, age-stratified data are scarce. The aim of this study was to provide information on the safety and efficacy of LAAC, with emphasis on the oldest patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A nationwide, prospective, multicentre, observational registry was established by 53 French cardiology centres in 2018\u20132021. The composite primary endpoint included ischaemic stroke, systemic embolism, and unexplained or cardiovascular death. Separate analyses were done in the groups &lt;80 years and \u226580 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the 1053 patients included, median age was 79.7 (73.6\u201384.3) years; 512 patients (48.6%) were aged \u226580 years. Procedure-related serious adverse events were non-significantly more common in octogenarians (7.0% vs 4.4% in patients aged &lt;80 years, respectively; p=0.07). Despite a higher mean CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score in octogenarians, the rate of thromboembolic events during the study was similar in both groups (3.0 vs 3.1\/100 patient-years; p=0.85). By contrast, all-cause mortality was significantly higher in octogenarians (15.3 vs 10.1\/100 patient-years, p&lt;0.015), due to a higher rate of non-cardiovascular deaths (8.2 vs 4.9\/100 patient-years, p=0.034). The rate of the primary endpoint was 8.1\/100 patient-years overall with no statistically significant difference between age groups (9.4 and 7.0\/100 patient-years; p=0.19).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Despite a higher mean CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score in octogenarians, the rate of thromboembolic events after LAAC in this age group was similar to that in patients aged &lt;80 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ClinicalTrials.gov Registry (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03434015\">NCT03434015<\/jats:ext-link>).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-322871","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:25:37Z","timestamp":1696857937000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Left atrial appendage closure in very elderly patients in the French National Registry"],"prefix":"10.1136","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct03434015","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Emmanuel","family":"Teiger","sequence":"first","affiliation":[{"name":"Department of Cardiology, APHP, Henri Mondor University Hospital, Cr\u00e9teil, France"},{"name":"Clinical Investigation Center 1430 and U955-IMRB team 3, Ecole Nationale V\u00e9t\u00e9rinaire d'Alfort, UPEC, INSERM, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Eschalier","sequence":"additional","affiliation":[{"name":"Cardiology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France"},{"name":"CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, University of Clermont Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Amabile","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institut Mutualiste Montsouris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-9050","authenticated-orcid":false,"given":"Gilles","family":"Rioufol","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Lyon Cardiovascular Hospital, Bron Cedex, France"},{"name":"CARMEN INSERM 1060, INSERM, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Ducrocq","sequence":"additional","affiliation":[{"name":"Department of Cardiology, FACT (French Alliance for Cardiovascular Trials), DHU-FIRE, Bichat-Claude Bernard University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Garot","sequence":"additional","affiliation":[{"name":"Institut Cardiovasculaire Paris-Sud (ICPS), Ramsay-Sant\u00e9, H\u00f4pital Priv\u00e9 Jacques Cartier, Massy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Lepillier","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bille","sequence":"additional","affiliation":[{"name":"Cardiology Department, Saint Joseph Hospital, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyer","family":"Elbaz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rangueil University Hospital, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Defaye","sequence":"additional","affiliation":[{"name":"Department of Rhythmology, Grenoble-Alpes University Hospital, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Audureau","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Public Health, Henri Mondor University Hospital, Creteil, France"},{"name":"Equipe CEpiA, INSERM, UPEC, U955-IMRB, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-9591","authenticated-orcid":false,"given":"Philippe","family":"Le Corvoisier","sequence":"additional","affiliation":[{"name":"Clinical Investigation Center 1430, APHP, Groupe Hospitalier Henri Mondor, Creteil, France"},{"name":"Clinical Investigation Center 1430 and U955-IMRB team 3, INSERM, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"2025092004425573000_110.4.245.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.08.022"},{"key":"2025092004425573000_110.4.245.2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/europace\/euaa126","article-title":"Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis","volume":"22","author":"Wu","year":"2020","journal-title":"Europace"},{"key":"2025092004425573000_110.4.245.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61233-1"},{"key":"2025092004425573000_110.4.245.4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.526988"},{"key":"2025092004425573000_110.4.245.5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014108","article-title":"Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF study","volume":"9","author":"Sanghai","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025092004425573000_110.4.245.6","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.4244\/EIJ-D-20-00201","article-title":"Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study","volume":"16","author":"Gloekler","year":"2020","journal-title":"EuroIntervention"},{"key":"2025092004425573000_110.4.245.7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2025092004425573000_110.4.245.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15192"},{"key":"2025092004425573000_110.4.245.9","doi-asserted-by":"crossref","first-page":"AA78","DOI":"10.4244\/EIJ-D-17-00412","article-title":"Left atrial appendage occlusion","volume":"13","author":"Nietlispach","year":"2017","journal-title":"EuroIntervention"},{"key":"2025092004425573000_110.4.245.10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"2025092004425573000_110.4.245.11","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY15M01_06"},{"key":"2025092004425573000_110.4.245.12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/europace\/euaa262","article-title":"Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer amulet Occluder observational study","volume":"23","author":"Freixa","year":"2021","journal-title":"Europace"},{"key":"2025092004425573000_110.4.245.13","first-page":"886","article-title":"Clinical benefit of left atrial appendage closure in octogenarians","volume":"18","author":"Mohrez","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"2025092004425573000_110.4.245.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"2025092004425573000_110.4.245.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61343-X"},{"key":"2025092004425573000_110.4.245.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.067"},{"key":"2025092004425573000_110.4.245.17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"2025092004425573000_110.4.245.18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2022.02.009","article-title":"Clinical outcomes at 1 year following transcatheter left atrial appendage occlusion in the United States","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025092004425573000_110.4.245.19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.recesp.2019.02.009","article-title":"Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION Registry","volume":"73","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2025092004425573000_110.4.245.20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2015.10.024","article-title":"Comparison of efficacy and safety of left atrial appendage occlusion in patients aged <75 to >\/= 75 years","volume":"117","author":"Freixa","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025092004425573000_110.4.245.21","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3390\/jcm9072295","article-title":"Major bleeding predictors in patients with left atrial appendage closure: the Iberian registry II","volume":"9","author":"L\u00f3pez-M\u00ednguez","year":"2020","journal-title":"JCM"},{"key":"2025092004425573000_110.4.245.22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.amjcard.2020.09.017","article-title":"Comparison in patients 75 years on one-year-events with atrial fibrillation and left atrial appendage occluder (from the prospective multicenter German LAARGE Registry)","volume":"136","author":"Nasasra","year":"2020","journal-title":"Am J Cardiol"},{"key":"2025092004425573000_110.4.245.23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacep.2023.02.007","article-title":"Left atrial appendage occlusion in the elderly: insights from PROTECT-AF, PREVAIL, and continuous access registries","volume":"9","author":"Sulaiman","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2025092004425573000_110.4.245.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr488"},{"key":"2025092004425573000_110.4.245.25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"key":"2025092004425573000_110.4.245.26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10840-022-01266-1","article-title":"Association of advanced age with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the National inpatient sample of 36,065 procedures","volume":"65","author":"Munir","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"key":"2025092004425573000_110.4.245.27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024574","article-title":"Short-term outcomes following left atrial appendage closure in the very elderly: a population-based analysis","volume":"11","author":"Farwati","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025092004425573000_110.4.245.28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025092004425573000_110.4.245.29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jcin.2021.11.037","article-title":"Age-related outcomes after transcatheter mitral valve repair in patients with heart failure: analysis from COAPT","volume":"15","author":"Song","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025092004425573000_110.4.245.30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.arcmed.2022.03.005","article-title":"Sex differences and temporal trends in revascularization and outcomes of ST-elevation myocardial infarction in older adults in the United States","volume":"53","author":"Ye","year":"2022","journal-title":"Arch Med Res"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-322871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:43:04Z","timestamp":1758368584000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-322871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/heartjnl-2023-322871"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-322871","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}